Search for: "JANSSEN PHARMACEUTICALS"
Results 1 - 20
of 570
Sort by Relevance
|
Sort by Date
27 May 2024, 9:26 pm
Cir. 2024)Janssen Pharmaceuticals, Inc. v. [read post]
28 Apr 2024, 8:18 pm
Cir. 2024)Janssen Pharmaceuticals, Inc. v. [read post]
14 Apr 2024, 9:19 pm
Noonan -- In its recent decision in Janssen Pharmaceuticals, Inc. v. [read post]
8 Apr 2024, 9:47 am
Vidal, with the pharmaceutical company challenging a PTAB IPR decision invalidating its patent. [read post]
1 Apr 2024, 10:58 am
by Dennis Crouch In April 2024, the Federal Circuit issued a significant decision vacating a district court’s judgment that Janssen Pharmaceuticals’ dosing regimen patent claims were nonobvious. [read post]
1 Apr 2024, 10:15 am
Court of Appeals for the Federal Circuit (CAFC) ruled in a precedential decision authored by Judge Prost on Monday that certain claims of Janssen Pharmaceuticals Inc. [read post]
1 Apr 2024, 10:15 am
Court of Appeals for the Federal Circuit (CAFC) ruled in a precedential decision authored by Judge Prost on Monday that certain claims of Janssen Pharmaceuticals Inc. [read post]
27 Mar 2024, 5:40 pm
Lykos’ MDMA is not just a pharmaceutical—it is a package deal, where patients receive several rounds (42 hours) of therapy to prepare and “integrate” their experience on MDMA. [read post]
27 Mar 2024, 12:00 am
Manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, Elmiron (pentosan polysulfate sodium) was approved by the FDA in 1996 to treat interstitial cystitis, a chronic bladder condition. [read post]
25 Mar 2024, 12:00 am
This has prompted numerous lawsuits against the drug's manufacturer, Janssen Pharmaceuticals, with the adequacy of Elmiron's safety warnings emerging as a critical issue. [read post]
7 Mar 2024, 5:00 am
For example, Spravato, Janssen Pharmaceutical’s intranasal S-ketamine product, comes with a REMS that mandates the product can only be given in an approved facility. [read post]
5 Mar 2024, 11:47 am
PLAINTIFF COURT AND DATE OF COMPLAINT SELECTED DRUGS (FOR YEAR 2026) Bristol Myers Squibb D.N.J. (16 June 2023) Eliquis Novartis D.N.J. (1 Sept. 2023) Entresto J&J’s Janssen Pharms. [read post]
4 Jan 2024, 9:42 am
Janssen Biotech, Inc., 759 F.3d 1285 (Fed. [read post]
20 Dec 2023, 5:00 am
Janssen 2014). [read post]
12 Dec 2023, 5:00 am
The disclosure of the records, and subsequent analysis thereof led by the HJI have revealed that not only was South Africa charged more for COVID-19 vaccines than countries in the Global North, but also that the terms and conditions that the state had to agree to were overwhelmingly one-sided, favouring multinational pharmaceutical companies (including Janssen Pharmaceuticals, which produces the J&J vaccine, as well as with Pfizer, and the Serum Institute of… [read post]
8 Dec 2023, 7:58 am
Janssen, 2014). [read post]
29 Nov 2023, 5:00 am
Which explains how sales are now on track to make three quarters of a billion dollars for Janssen over the next year. [read post]
28 Oct 2023, 8:44 am
Case Citation: Janssen Products LP v. [read post]
4 Oct 2023, 10:00 pm
The Plaintiffs in the remaining five lawsuits (Merck, Bristol Myers Squibb, PhRMA and other trade associations, Janssen pharmaceutical, and Boehringer Ingelheim) might similarly amend their complaints to note that their drugs were in fact selected, and that they were compelled to sign contracts with the CMS. [read post]
5 Dec 2022, 6:55 am
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
